Recombinant human interferon-gamma in patients with chronic granulomatous disease —European follow up study
- 1 April 1995
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in European Journal of Pediatrics
- Vol. 154 (4), 295-298
- https://doi.org/10.1007/bf01957365
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- A Controlled Trial of Interferon Gamma to Prevent Infection in Chronic Granulomatous DiseaseNew England Journal of Medicine, 1991
- Partial Correction of the Phagocyte Defect in Patients with X-Linked Chronic Granulomatous Disease by Subcutaneous Interferon GammaNew England Journal of Medicine, 1988
- Recombinant human interferon-gamma reconstitutes defective phagocyte function in patients with chronic granulomatous disease of childhood.Proceedings of the National Academy of Sciences of the United States of America, 1988
- Clinical Features and Current Management of Chronic Granulomatous DiseaseHematology/Oncology Clinics of North America, 1988
- Recombinant interferon gamma augments phagocyte superoxide production and X-chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease.JCI Insight, 1987
- Chronic Granulomatous DiseasePediatric Clinics of North America, 1977